AddLife AB (publ) (ALIF-B)
Nasdaq Stockholm · Sweden · prices in SEK · close of 27 Oct 2026
Key indicators
| Last close | SEK 181.30 |
|---|---|
| 52-week range | 130.20 – 207.60 |
| Return, 1 month / 3 months | +6.6% / +15.0% |
| Return, 1 year / 3 years | −10.8% / +180.6% |
| Trend | Uptrend |
| RSI (14) | 59 |
| Volatility (1 year) | 34.7% |
| Worst drawdown (1 year) | -34.9% |
| Average daily value traded | 28.30M SEK |
| Dividend yield | 0.8% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
AddLife is a Swedish life science group that owns and develops companies supplying products and services to healthcare, research and industry. Through its Labtech and Medtech business areas, it provides laboratory equipment, medical technology devices, consumables and related services. Its customers include hospitals, laboratories, universities and industrial firms, mainly in Europe. The company is based in Sweden and operates through a group of subsidiary businesses.
AddLife AB (publ) trades under the code ALIF-B on the Nasdaq Stockholm in Sweden, with its price quoted in Swedish kronor (SEK). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
AddLife AB (publ) (ALIF-B) trades on the Nasdaq Stockholm in Sweden. It last closed at SEK 181.30 on 27 October 2026.
Its price-based Market X-Ray is 69 out of 100 (a fair price profile), ranking 207 of 912 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 10.8% and over the last three months it rose 15.0%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Nasdaq Stockholm
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 82 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 16.8% | ||
| From 52-week high | -12.0% | ||
| Momentum | 70 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 15.0% | ||
| 6-month return | 20.6% | ||
| 12-month return, skipping the last month | -16.3% | ||
| Stability (higher is calmer) | 65 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 34.7% | ||
| Worst drawdown, 1 year (smaller is calmer) | -34.9% | ||
| Liquidity | 88 · Strong | Trades actively. | |
| Average daily value traded | 28.30M SEK | ||
| Zero-volume days | 0.0% | ||
| Income | 18 · Weak | Dividend is small or irregular. | |
| Dividend yield | 0.8% | ||
| Years with dividends | 4 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Liquidity: Trades actively.
Weak spots
- Income: Dividend is small or irregular.
Returns
| 1 week | −2.1% |
|---|---|
| 1 month | +6.6% |
| 3 months | +15.0% |
| 6 months | +20.6% |
| 1 year | −10.8% |
| 3 years | +180.6% |
| 5 years | −47.9% |
Signals
| 50-day / 200-day average | 168.66 / 155.18 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 5.32 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 7 May 2026 | SEK 1.5000 |
| 9 May 2025 | SEK 0.7500 |
| 10 May 2024 | SEK 0.5000 |
| 6 May 2022 | SEK 2.0000 |
| 6 May 2021 | SEK 1.5000 |
| 20 Nov 2020 | SEK 0.5000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Nasdaq Stockholm; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.